Regulation of the cell cycle inhibitor p27 and its ubiquitin ligase Skp2 in differentiation of human embryonic stem cells

2007 ◽  
Vol 21 (11) ◽  
pp. 2807-2817 ◽  
Author(s):  
Dana Egozi ◽  
Maanit Shapira ◽  
Galit Paor ◽  
Ofer Ben‐Izhak ◽  
Karl Skorecki ◽  
...  
2016 ◽  
Vol 01 (03) ◽  
pp. 201-208 ◽  
Author(s):  
Malini Krishnamoorthy ◽  
Brian Gerwe ◽  
Jamie Heimburg-Molinaro ◽  
Rachel Nash ◽  
Jagan Arumugham ◽  
...  

2013 ◽  
Vol 85 (19) ◽  
pp. 8996-9002 ◽  
Author(s):  
Stanislav O. Konorov ◽  
H. Georg Schulze ◽  
James M. Piret ◽  
Michael W. Blades ◽  
Robin F. B. Turner

2007 ◽  
Vol 1 (1) ◽  
pp. 45-60 ◽  
Author(s):  
Adam A. Filipczyk ◽  
Andrew L. Laslett ◽  
Christine Mummery ◽  
Martin F. Pera

Stem Cells ◽  
2014 ◽  
Vol 32 (8) ◽  
pp. 2098-2110 ◽  
Author(s):  
Hui Zhu ◽  
Shijun Hu ◽  
Julie Baker

2009 ◽  
Vol 184 (1) ◽  
pp. 67-82 ◽  
Author(s):  
Xin Zhang ◽  
Irina Neganova ◽  
Stefan Przyborski ◽  
Chunbo Yang ◽  
Michael Cooke ◽  
...  

In this study, we show that NANOG, a master transcription factor, regulates S-phase entry in human embryonic stem cells (hESCs) via transcriptional regulation of cell cycle regulatory components. Chromatin immunoprecipitation combined with reporter-based transfection assays show that the C-terminal region of NANOG binds to the regulatory regions of CDK6 and CDC25A genes under normal physiological conditions. Decreased CDK6 and CDC25A expression in hESCs suggest that both CDK6 and CDC25A are involved in S-phase regulation. The effects of NANOG overexpression on S-phase regulation are mitigated by the down-regulation of CDK6 or CDC25A alone. Overexpression of CDK6 or CDC25A alone can rescue the impact of NANOG down-regulation on S-phase entry, suggesting that CDK6 and CDC25A are downstream cell cycle effectors of NANOG during the G1 to S transition.


Sign in / Sign up

Export Citation Format

Share Document